---  
layout: startup_page  
title: "FORE Biotherapeutics"  
id: "fore.bio"  
permalink: "/forebiotherapeuticsfore.bio05222025/"  
website: "https://www.fore.bio/"  
funding_round: "Series D2"  
funding_amount: "$38M"  
investors: "SR One, Medicxi, OrbiMed, HBM Healthcare Investments, Wellington Management, Novartis Venture Fund, Cormorant Asset Management, 3B Future Health Fund"  
about: "FORE Biotherapeutics is a registration stage biotherapeutics company focused on developing targeted therapies for cancer patients. Their lead asset, plixorafenib, is a BRAF inhibitor designed to address treatment gaps in various tumor types."  
markets: "Biotech, Oncology, Therapeutics"  
hq: "Philadelphia, Pennsylvania, United States"  
founded_year: ""  
linkedin: "https://www.linkedin.com/company/forebiotherapeutics"  
twitter: "https://x.com/ForeBiotx"  
instagram: ""  
facebook: ""  
crunchbase: ""  
pitchbook: ""  

date_display: "22-May-2025"  
date: "2025-05-22"

# SEO Optimization  
meta_title: "FORE Biotherapeutics - Series D2 Funding ($38M)"  
meta_description: "FORE Biotherapeutics, FORE Biotherapeutics is a registration stage biotherapeutics company focused on developing targeted therapies for cancer patients. Their lead asset, p..."  
meta_keywords: "FORE Biotherapeutics, Biotech, Oncology, Therapeutics, Series D2 funding"  
canonical_url: "https://startup.projectstartups.com/forebiotherapeuticsfore.bio05222025/"  
---